Results 61 to 70 of about 47,447 (260)

Diffuse gallbladder epithelial proliferation after teduglutide exposure: A case report

JPGN Reports, EarlyView.
Abstract Teduglutide, a glucagon‐like peptide 2 analog that increases mucosal proliferation in the gastrointestinal tract, was approved by the U.S. Food and Drug Administration for use in children with intestinal failure in 2019 after trials of 12‐ and 24‐week duration.
Christopher P. Duggan, Alexandra N. Carey, Megan McGivney, Mark Puder, Antonio R. Perez‐Atayde   +4 more
wiley   +1 more source

Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets

BMC Cancer
Background Traditional nanodrug delivery systems have some limitations, such as eliciting immune responses and inaccuracy in targeting tumor microenvironments.
Xuanbo Da, Bangping Cao, Jiantao Mo, Yukai Xiang, Hai Hu, Chen Qiu, Cheng Zhang, Beining Lv, Honglei Zhang, Chuanqi He, Yulong Yang   +10 more
doaj   +1 more source

Effect of early-life exposure to environmental risk factors on adult MASLD: Insights from DOHaD perspective

生物医学转化
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease globally, affecting approximately 30% of the adult population.
Zhang Hongchao, Francisco Javier Cubero, Zhao Gang, Xu Jin, Liu Qian, Shao Wentao, Gu Aihua   +6 more
doaj   +1 more source

Jejunal perforation in gallstone ileus – a case series

Journal of Medical Case Reports, 2007
Introduction Gallstone ileus is an uncommon complication of cholelithiasis but an established cause of mechanical bowel obstruction in the elderly. Perforation of the small intestine proximal to the obstructing gallstone is rare, and only a handful of ...
Browning Louise E, Taylor Jeremy D, Clark Sue K, Karanjia Nariman D   +3 more
doaj   +1 more source

Kaplan-Meier 6-year CVD event free probability curves for gallstone and non-gallstone disease groups.

, 2013
Kaplan-Meier 6-year CVD event free probability curves for gallstone and non-gallstone disease groups.
Hung-Yi Chiou (125267), Jiann-Shing Jeng (125224), Muideen Tunbosun Olaiya (466392), Li-Ming Lien (125232), Fang-I Hsieh (125259)   +4 more
core   +1 more source

Cholecystectomy for Gallstone: Types and Findings [PDF]

, 2020
Gall stone disease remains a common and significant cause of suffering in most parts of the world. Gallstones are the most common biliary pathology. A descriptive study covered 80 patients underwent surgical treatment for gallstone diseases.
Abd-Rhida Atiea, Hassan, Abid-Saaidan, Majid, Majeed, Nada Saadi   +2 more
core  

Sickle Cell Disease: Historical Overview and Current Therapies

Prenatal Diagnosis, EarlyView.
ABSTRACT Sickle cell disease (SCD) affects millions worldwide, yet the limited treatment options currently available do not always adequately control the disease and carry significant side effects. At present, the only curative treatment is hematopoietic stem cell (HSC) transplantation, a procedure that carries considerable challenges and numerous ...
Oluwaseun O. Babatunde, Madeleine G. Bibby, Anthony Atala, Graça Almeida‐Porada, Christopher D. Porada   +4 more
wiley   +1 more source

A variant of the SLC10A2 gene encoding the apical sodium-dependent bile acid transporter is a risk factor for gallstone disease. [PDF]

PLoS ONE, 2009
BACKGROUND:Cholelithiasis is a multifactorial process and several mechanisms of gallstone formation have been postulated. As one of these mechanisms, a decreased expression of the ileal apical sodium-dependent bile acid transporter gene SLC10A2 in ...
Olga Renner, Simone Harsch, Elke Schaeffeler, Stefan Winter, Matthias Schwab, Marcin Krawczyk, Jonas Rosendahl, Henning Wittenburg, Frank Lammert, Eduard F Stange   +9 more
doaj   +1 more source

Ruta graveolens L. in Evidence‐Based Phytotherapy: Pharmacological Activities, Bioactive Compounds and Safety

Phytotherapy Research, EarlyView.
Graphical representation of ethnomedical uses, major bioactive compounds, pharmacological potential and toxicological risks of Ruta graveolens L. ABSTRACT Ruta graveolens L. is widely used in traditional European, Asian, African, and South American medicine for digestive, nervous, cardiovascular, respiratory, and reproductive disorders.
Tetiana Serhiienko, Victoriya Georgiyants, Liudas Ivanauskas, Olha Mykhailenko   +3 more
wiley   +1 more source

Clinical characteristics of hospitalized patients with benign gallbladder disease: a large-scale retrospective analysis

BMC Gastroenterology
Background Benign gallbladder disease, including gallstones, gallbladder polyps, and gallbladder adenomyosis, is one of the most common disorders of the digestive system worldwide and poses a substantial clinical and economic burden.
Honglei Zhang, Cheng Zhang, Chen Qiu, Yukai Xiang, Zhaoyan Jiang, Liang Zheng, Hai Hu, Yulong Yang   +7 more
doaj   +1 more source